跳至主要内容
临床试验/IRCT2015062922142N2
IRCT2015062922142N2已完成2 期

The effect of omega-3 versus placebo on the clinical and paraclinical signs and symptoms of drug-resistant epileptic patients: a triple blind randomized clinical trial

hamadan university of medical sciences, Vice-chancellor for research and technology , Hamedan0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • drug resistant epilepsy; 18 to 65 years old.
  • Exclusion criteria: patients with impaired renal function; patients with catamenial seizure; Patients with hepatic dysfunction; Patients with active infection; Patients with brain or mental dysfunction; Patients who can not take oral medication; Patients treated with anti-inflammatory or antioxidant drugs in the past month; patients with other concurrent inflammatory disease; Patients who can not tolerate the side effects; Patients who are pregnant or lactating

排除标准

  • 未提供

研究者

发起方
hamadan university of medical sciences, Vice-chancellor for research and technology , Hamedan

相似试验